1. Home
  2. TVTX vs VTLE Comparison

TVTX vs VTLE Comparison

Compare TVTX & VTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • VTLE
  • Stock Information
  • Founded
  • TVTX 2008
  • VTLE 2006
  • Country
  • TVTX United States
  • VTLE United States
  • Employees
  • TVTX N/A
  • VTLE N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • VTLE
  • Sector
  • TVTX Health Care
  • VTLE
  • Exchange
  • TVTX Nasdaq
  • VTLE Nasdaq
  • Market Cap
  • TVTX 1.3B
  • VTLE 1.2B
  • IPO Year
  • TVTX N/A
  • VTLE 2011
  • Fundamental
  • Price
  • TVTX $17.72
  • VTLE $30.66
  • Analyst Decision
  • TVTX Buy
  • VTLE Hold
  • Analyst Count
  • TVTX 13
  • VTLE 13
  • Target Price
  • TVTX $23.46
  • VTLE $47.91
  • AVG Volume (30 Days)
  • TVTX 1.4M
  • VTLE 849.1K
  • Earning Date
  • TVTX 10-31-2024
  • VTLE 11-06-2024
  • Dividend Yield
  • TVTX N/A
  • VTLE N/A
  • EPS Growth
  • TVTX N/A
  • VTLE N/A
  • EPS
  • TVTX N/A
  • VTLE 13.16
  • Revenue
  • TVTX $203,447,000.00
  • VTLE $1,862,465,000.00
  • Revenue This Year
  • TVTX $62.45
  • VTLE $28.07
  • Revenue Next Year
  • TVTX $59.30
  • VTLE $7.97
  • P/E Ratio
  • TVTX N/A
  • VTLE $2.35
  • Revenue Growth
  • TVTX 57.08
  • VTLE 26.94
  • 52 Week Low
  • TVTX $5.12
  • VTLE $25.85
  • 52 Week High
  • TVTX $20.33
  • VTLE $58.30
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 51.53
  • VTLE 62.67
  • Support Level
  • TVTX $16.89
  • VTLE $29.51
  • Resistance Level
  • TVTX $19.51
  • VTLE $32.24
  • Average True Range (ATR)
  • TVTX 1.23
  • VTLE 1.38
  • MACD
  • TVTX -0.16
  • VTLE 0.50
  • Stochastic Oscillator
  • TVTX 26.69
  • VTLE 86.72

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

About VTLE Vital Energy Inc. par value $0.01 per share

Vital Energy is an independent energy company. Its business is focused on the acquisition, exploration, and development of oil and natural gas properties in the Permian Basin of West Texas. The Company has identified one operating segment: exploration and production.

Share on Social Networks: